FINWIRES · TerminalLIVE
FINWIRES

Mizuho Adjusts Price Target on Axsome Therapeutics to $228 From $230, Maintains Outperform Rating

作者

-- Axsome Therapeutics (AXSM) has an average rating of buy and mean price target of $222.90, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $185.08, Change: $+0.08, Percent Change: +0.04%

相關文章